78 related articles for article (PubMed ID: 4658408)
21. Phase II trial of diaziquone in advanced renal adenocarcinoma.
Hansen M; Gallmeier WM; Vermorken J; Holdener E; Hansen HH; Renard J; Rozencweig M
Cancer Treat Rep; 1984; 68(7-8):1055-6. PubMed ID: 6744342
[No Abstract] [Full Text] [Related]
22. [Iodochlorometric determination of dopan, thiophosphamide, thiodipin and imiphos].
Kozlov NE; Sbezhneva VG
Farmatsiia; 1976; 25(3):89-90. PubMed ID: 820575
[No Abstract] [Full Text] [Related]
23. [Attack treatment of broncho-pleuro-pulmonary cancer by polychemotherapy under the protection of phytohemagglutinin].
Brocard H; Akoun G; Turpin G; Gendre JP
Bull Mem Soc Med Hop Paris; 1967 Jan; 118(2):139-56. PubMed ID: 6061578
[No Abstract] [Full Text] [Related]
24. [Clinical significance of mustoforan in management of malignant glioma].
Kobiakov GL
Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
[No Abstract] [Full Text] [Related]
25. [Anticancer chemotherapy with evaluation of combined treatments].
Saito T
Poumon Coeur; 1968; 24(1):129-31. PubMed ID: 5652199
[No Abstract] [Full Text] [Related]
26. Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Griffin JP; Newman RA; McCormack JJ; Krakoff IH
Cancer Treat Rep; 1982 Jun; 66(6):1321-5. PubMed ID: 7083235
[TBL] [Abstract][Full Text] [Related]
27. Phase II clinical evaluation of AZQ in metastatic breast cancer.
Yap HY; Bedikian AY; Schell FC; Blumenschein GR; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):31-3. PubMed ID: 6837505
[TBL] [Abstract][Full Text] [Related]
28. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
[No Abstract] [Full Text] [Related]
29. [Polychemotherapy of bronchopulmonary cancers (apropos of 21 cases)].
Battesti JP
Poumon Coeur; 1968; 24(1):28-31. PubMed ID: 5652204
[No Abstract] [Full Text] [Related]
30. [Determination of individual sensitivity of malignant ovarian neoplasms to antineoplastic drugs].
Kulik GI; Abragam KA
Pediatr Akus Ginekol; 1969; 5():59-61. PubMed ID: 4994616
[No Abstract] [Full Text] [Related]
31. Long-term survival and secondary acute leukemia after fotemustine therapy for metastatic melanoma.
Gill S; Shapiro J; Westerman D; Prince HM
J Clin Oncol; 2007 Oct; 25(28):4493-4. PubMed ID: 17906211
[No Abstract] [Full Text] [Related]
32. Management of polycythemia vera with hydroxyurea.
Tatarsky I; Sharon R
Semin Hematol; 1997 Jan; 34(1):24-8. PubMed ID: 9025159
[No Abstract] [Full Text] [Related]
33. Interferon alfa: effects of long-term treatment for polycythemia vera.
Silver RT
Semin Hematol; 1997 Jan; 34(1):40-50. PubMed ID: 9025161
[No Abstract] [Full Text] [Related]
34. [Pipobroman in the treatment of some cases of polycythemia vera].
Bignotti G; Visca U; Confalonieri C
Haematologica; 1971; 56(3):157-62. PubMed ID: 5003588
[No Abstract] [Full Text] [Related]
35. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
Penttilä O; Ikkala E
Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
[No Abstract] [Full Text] [Related]
36. Phase II trial of thioproline in advanced epidermoid head and neck tumors.
Boccardo F; Barbieri A; Canobbio L; Guarneri D; Merlano M; Rosso R
Cancer Treat Rep; 1982 Mar; 66(3):585-6. PubMed ID: 7060048
[No Abstract] [Full Text] [Related]
37. [The effect of various antitumor drugs on developing Schwez erythromyelosis in rats].
Emanuel' NM; Dronova LM; Erokhin VN; Belich EI
Izv Akad Nauk SSSR Biol; 1970; 1():87-92. PubMed ID: 5275614
[No Abstract] [Full Text] [Related]
38. [Treatment of polycythemia with myelosan under ambulatory conditions].
Krasiukova LI
Probl Gematol Pereliv Krovi; 1975 May; 20(5):37-40. PubMed ID: 1144332
[No Abstract] [Full Text] [Related]
39. [Mechanism of action of antineoplastic agents].
Korolkovas A
Rev Farm Bioquim Univ Sao Paulo; 1971; 9(1):1-60. PubMed ID: 4948630
[No Abstract] [Full Text] [Related]
40. Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia.
Carmosino I; Latagliata R; Avvisati G; Breccia M; Finolezzi E; Lo Coco F; Petti MC
Haematologica; 2004 May; 89(5):615-7. PubMed ID: 15136230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
